Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications

NCT05518123 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

658

Enrollment

INDUSTRY

Sponsor class

Conditions

Migraine

Interventions

DRUG: Rimegepant
DRUG: Placebo

Sponsor

Pfizer